Agilon Health, Inc. (AGL)
89.71
-0.58
(-0.64%)
USD |
NYSE |
Oct 23, 16:00
89.64
-0.06
(-0.07%)
After-Hours: 20:00
Agilon Health Enterprise Value : 1.282B for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.282B |
| October 22, 2026 | 1.292B |
| October 21, 2026 | 1.303B |
| October 20, 2026 | 1.316B |
| October 19, 2026 | 1.267B |
| October 16, 2026 | 1.205B |
| October 15, 2026 | 1.261B |
| October 14, 2026 | 1.243B |
| October 13, 2026 | 1.218B |
| October 12, 2026 | 1.211B |
| October 09, 2026 | 1.159B |
| October 08, 2026 | 1.198B |
| October 07, 2026 | 1.215B |
| October 06, 2026 | 1.176B |
| October 05, 2026 | 1.191B |
| October 02, 2026 | 1.188B |
| October 01, 2026 | 1.157B |
| September 30, 2026 | 1.112B |
| September 29, 2026 | 1.088B |
| September 28, 2026 | 1.111B |
| September 25, 2026 | 1.131B |
| September 24, 2026 | 1.049B |
| September 23, 2026 | 1.196B |
| September 22, 2026 | 1.234B |
| September 21, 2026 | 1.254B |
| Date | Value |
|---|---|
| September 18, 2026 | 1.273B |
| September 17, 2026 | 1.273B |
| September 16, 2026 | 1.281B |
| September 15, 2026 | 1.322B |
| September 14, 2026 | 1.327B |
| September 11, 2026 | 1.283B |
| September 10, 2026 | 1.330B |
| September 09, 2026 | 1.347B |
| September 08, 2026 | 1.310B |
| September 04, 2026 | 1.262B |
| September 03, 2026 | 1.228B |
| September 02, 2026 | 1.243B |
| September 01, 2026 | 1.244B |
| August 31, 2026 | 1.251B |
| August 28, 2026 | 1.329B |
| August 27, 2026 | 1.357B |
| August 26, 2026 | 1.383B |
| August 25, 2026 | 1.389B |
| August 24, 2026 | 1.350B |
| August 21, 2026 | 1.397B |
| August 20, 2026 | 1.333B |
| August 19, 2026 | 1.348B |
| August 18, 2026 | 1.377B |
| August 17, 2026 | 1.402B |
| August 14, 2026 | 1.403B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Astrana Health, Inc. | 2.189B |
| Starling Oncology, Inc. | 737.53M |
| Nakamoto, Inc. | 277.34M |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | 265.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 17.96M |
| Revenue (Quarterly) | 1.495B |
| Total Expenses (Quarterly) | 1.477B |
| EPS Diluted (Quarterly) | 1.043 |
| Gross Profit Margin (Quarterly) | 6.71% |
| Profit Margin (Quarterly) | 1.20% |
| Earnings Yield | -16.94% |
| Normalized Earnings Yield | -14.36 |